At the news
? NEUTRALIMPACT 2/10 13F-HR filed Nov 12, 2026 at 13:37 ET
Franklin Templeton's Q3 2026 13F shows a portfolio valued at $473.6B, with top holdings in mega-cap tech (Apple, Microsoft, Amazon, Alphabet, Nvidia) and large pharma (Eli Lilly, AbbVie, AstraZeneca). The filing follows a mixed Q4 FY2026 earnings report (GAAP EPS miss but adjusted EPS +40% YoY, record AUM of $1.8T). The portfolio reflects a diversified, index-like structure consistent with a large asset manager, with no aggressive sector rotation evident from the snapshot.
- Total portfolio value: $473,567,641,578 as of September 30, 2026
- Top holdings include Apple (~$6.75B), Microsoft, Amazon, Alphabet, Nvidia, Eli Lilly, AbbVie, AstraZeneca, Broadcom, and Meta Platforms
- Filing follows Q4 FY2026 earnings: GAAP EPS $0.72 (missed consensus $0.77), adjusted diluted EPS $0.94 (+40% YoY), revenue $2.43B (slight beat), record AUM $1.8T
- Portfolio is highly diversified across sectors and market caps, consistent with a multi-strategy asset manager
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access